In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Naftilong Drug Master File in Korea (Naftilong KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Naftilong. The MFDS reviews the Naftilong KDMF as part of the drug registration process and uses the information provided in the Naftilong KDMF to evaluate the safety and efficacy of the drug.
After submitting a Naftilong KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Naftilong API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Naftilong suppliers with KDMF on PharmaCompass.